FDA Awards Wyss Institute $5.6M for Organs-on-Chips Technology in Assessing Radiation Sickness Countermeasures | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration announced on Monday that it has awarded Harvard University's Wyss Institute for Biologically Inspired Engineering a $5.6 million contract to assess medical countermeasures for treating radiation sickness using Wyss' organs-on-chips technology.

In work carried out as part of the award, researchers at Wyss will develop models of radiation damage in lung, gut, and bone marrow organs-on-chips and then test possible medical countermeasures for radiation sickness on the models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.